thumbnail
Deal MakingIntellia and ReCode partner to develop gene-editing therapies against CFIntellia and ReCode partner to develop gene-editing therapies against CF
Intellia and ReCode Therapeutics have entered into a partnership to develop genomic medicines for the treatment of cystic fibrosis (CF).